New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosisBEISIEGEL, U.Atherosclerosis. 1996, Vol 124, Num 1, pp 1-8, issn 0021-9150Article

CHARGE-SHIFT ELECTROPHORESIS OF APOLIPOPROTEINS FROM NORMAL HUMANS AND PATIENTS WITH TANGIER DISEASEUTERMANN G; BEISIEGEL U.1979; F.E.B.S. LETTERS; NLD; DA. 1979; VOL. 97; NO 2; PP. 245-248; BIBL. 21 REF.Article

Lipoprotein metabolismBEISIEGEL, U.European heart journal. 1998, Vol 19, Num FEV, pp A20-A23, issn 0195-668X, SUPAConference Paper

MONOCLONAL ANTIBODIES TO THE LOW DENSITY LIPOPROTEIN RECEPTOR AS PROBES FOR STUDY OF RECEPTOR-MEDIATED ENDOCYTOSIS AND THE GENETICS OF FAMILIAL HYPERCHOLESTEROLEMIA = ANTICORPS MONOCLONAUX CONTRE LE RECEPTEUR LIPOPROTEIQUE DE FAIBLE DENSITE EN TANT QUE METHODE D'ETUDE DE L'ENDOCYTOSE DIRIGEE PAR LES RECEPTEURS ET LA GENETIQUE DE L'HYPERCHOLESTEROLEMIE FAMILIALEBEISIEGEL U; SCHNEIDER WJ; GOLDSTEIN JL et al.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 22; PP. 11923-11931; BIBL. 24 REF.Article

Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicronsOLIVECRONA, G; BEISIEGEL, U.Arteriosclerosis, thrombosis, and vascular biology. 1997, Vol 17, Num 8, pp 1545-1549, issn 1079-5642Article

ANTIBODY AGAINST LOW DENSITY LIPOPROTEIN RECEPTOR BLOCKS UPTAKE OF LOW DENSITY LIPOPROTEIN (BUT NOT HIGH DENSITY LIPOPROTEIN) BY THE ADRENAL GLAND OF THE MOUSE IN VIVOKITA T; BEISIEGEL U; GOLDSTEIN JL et al.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 10; PP. 4701-4703; BIBL. 14 REF.Article

GENETICS OF THE APOLIPOPROTEIN E SYSTEM IN MANUTERMANN G; CANGENBECH U; BEISIEGEL U et al.1980; AMER. J. HUM. GENET.; USA; DA. 1980; VOL. 32; NO 3; PP. 339-347; BIBL. 14 REF.Article

Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related proteinBEISIEGEL, U; WEBER, W; BENGTSSON-OLIVECRONA, G et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 19, pp 8342-8346, issn 0027-8424Article

Antiatherosclerotic effect of probucol in WHHL rabbits : are there plasma parameters to evaluate this effect ?FINCKH, B; NIENDORF, A; RATH, M et al.European journal of clinical pharmacology. 1991, Vol 40, pp S77-S80, issn 0031-6970, SUP1Conference Paper

Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbitsBRAESEN, J. H; BEISIEGEL, U; NIENDORF, A et al.Virchows Archiv. 1995, Vol 426, Num 2, pp 179-188, issn 0945-6317Article

Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid contentKONTUSH, A; HÜBNER, C; FINCKH, B et al.FEBS letters. 1994, Vol 341, Num 1, pp 69-73, issn 0014-5793Article

Lack of association between a human β-2 adrenoceptor gene polymorphism (gln27glu) and morbid obesityKORTNER, B; WOLF, A; WENDT, D et al.International journal of obesity. 1999, Vol 23, Num 10, pp 1099-1100, issn 0307-0565Article

SEVERE TANGIER DISEASE WITH A NOVEL ABCA1 GENE MUTATIONSCHIPPLING, S; ORTH, M; BEISIEGEL, U et al.Neurology. 2008, Vol 71, Num 18, pp 1454-1455, issn 0028-3878, 2 p.Article

Apolipoprotein E serum concentration and polymorphism in six European countries :the ApoEurope ProjectSCHIELE, F; DE BACQUER, D; VISVIKIS, S et al.Atherosclerosis. 2000, Vol 152, Num 2, pp 475-488, issn 0021-9150Article

Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNAKOSCHINSKY, M. L; BEISIEGEL, U; HENNE-BRUNS, D et al.Biochemistry (Easton). 1990, Vol 29, Num 3, pp 640-644, issn 0006-2960, 5 p.Article

Association between the P12A and cl431t polymorphisms in the peroxisome proliferator activated receptor γ (PPARγ) gene and type 2 diabetesEVANS, D; DE HEER, J; HAGEMANN, C et al.Experimental and clinical endocrinology & diabetes. 2001, Vol 109, Num 3, pp 151-154, issn 0947-7349Article

Plasma ubiquinol-10 is decreased in patients with hyperlipidaemiaKONTUSH, A; REICH, A; BAUM, K et al.Atherosclerosis. 1997, Vol 129, Num 1, pp 119-126, issn 0021-9150Conference Paper

Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, on lipid metabolism in an open randomized trialBRILL, K; THEN, A; BEISIEGEL, U et al.Contraception (Stoneham). 1996, Vol 54, Num 5, pp 291-297, issn 0010-7824Article

Apolipoprotein E and lipoprotein lipase co-ordinately enhance binding and uptake of chylomicrons by human hepatocytesMANN, W. A; MEYER, N; WEBER, W et al.European journal of clinical investigation. 1995, Vol 25, Num 11, pp 880-882, issn 0014-2972Article

The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoformsVAN DER HOEK, Y. Y; WITTEKOEK, M. E; BEISIEGEL, U et al.Human molecular genetics (Print). 1993, Vol 2, Num 4, pp 361-366, issn 0964-6906Article

The α₂-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and β-migrating very low density lipoprotein associated with the lipaseNYKJÆR, A; BENGTSSON-OLIVECRONA, G; LOOKENE, A et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 20, pp 15048-15055, issn 0021-9258Article

Elevated lipoprotein(a) levels in patients with acute myeloblastic leukaemia decrease after sucessful chemotherapeutic treatmentNIENDORF, A; STANG, A; BEISIEGEL, U et al.(The) Clinical investigator. 1992, Vol 70, Num 8, pp 683-685Article

Therapeutic dose of HIV-1 protease inhibitor saquinavir does not permanently influence Early insulin signalingALGENSTAEDT, P; DANESHI, S; SCHWARZLOH, B et al.Experimental and clinical endocrinology & diabetes. 2003, Vol 111, Num 8, pp 491-498, issn 0947-7349, 8 p.Article

Association between polymorphisms in candidate genes and morbid obesityEVANS, D; WOLF, A. M; NELLESSEN, U et al.International journal of obesity. Supplement. 2001, Vol 25, Num 1, pp S19-S21, issn 1359-6373Conference Paper

Nonphysiological overexpression of low-density lipoprotein receptors causes pathological intracellular lipid accumulation and the formation of cholesterol and cholesteryl ester crystals in vitroHEEREN, J; STEINWAERDER, D. S; SCHNIEDERS, F et al.Journal of molecular medicine (Berlin. Print). 1999, Vol 77, Num 10, pp 735-743, issn 0946-2716Article